Maslimomab is a mouse monoclonal antibody and an immunosuppressive drug.

It was originally developed in mice as a mouse antibody.

Minretumomab is a mouse monoclonal antibody designed for the treatment of cancer.

Pemtumomab (trade name Theragyn) is a mouse monoclonal antibody used to treat cancer.

The secondary antibodies used were cy3-conjugated anti-rat or mouse antibody at 1:200.

A second application involves making mouse antibodies against important plant viruses and fungi.

But mouse antibodies do not work well as drugs because the patient's immune system attacks them as foreign invaders.

This was first done in 1989, with a mouse antibody made by tobacco plants.

It has been relatively easy to produce mouse monoclonal antibodies against a great many substances, but much more difficult to do this with human monoclonals.

They utilized a mouse bispecific antibody with two active sites performing different functions.